France· FR:62204255
AMLODIPINE VIATRIS GENERIQUES 5 mg, gélule
A medicinal product containing amlodipine (bésilate d'), registered in France by VIATRIS UP, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- AMLODIPINE (BÉSILATE D')
- Manufacturer
- VIATRIS UP
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip133400933341671plaquette(s) PVC PVDC aluminium de 30 gélule(s)EUR 3.01
- cip133400938235296plaquette(s) PVC PVDC aluminium de 90 gélule(s)EUR 8.06
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Amlodipine (bésilate d') in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumAmlor 5 mgViatris Healthcare
- IrelandIstin 5 mg hard capsuleViatris Healthcare Limited
- CzechiaAGENZentiva, k.s., Praha
- United Statesamlodipine besylateMylan Pharmaceuticals Inc.
- United KingdomAmdelta 10mg orodispersible tabletsAustin McNeil Ltd
- FinlandAloxicinKRKA Pharma Dublin Limited
- ItalyABISA.G.I.P.S. FARMACEUTICI S.R.L.
- PolandAdipineBausch Health Ireland Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Amlodibene Teva, Amlodilan
- Belgium · Amlodipin Ab, Amlodipin Besilaat Sandoz
- Bulgaria · Nordipin 10 Mg, Nordipin 5 Mg
- Cyprus · Afiten, Amlobe
- Czechia · Agen, Amlodipin Teva
- Germany · Amlo Besilat Tad, Amlodipin (Besilat) Dexcel
- Denmark · Adipine, Amlodipin 1a Farma
- Estonia · Agen, Amlocard
- Spain · Amlodipino Almus, Amlodipino Alter
- Finland · Amlodipin Accord, Amlodipin Krka
- United Kingdom (Northern Ireland) · Amlodipine, Amlodipine Accord Healthcare
- Greece · Abesyl, Amilopid
- Croatia · Amlodipin Genericon, Amlodipin Pharmas
- Hungary · Amlobesyl, Amlodipin Sandoz
- Ireland · Amlode, Amlodipine 10 Mg
- Iceland · Amló, Amlodipin Bluefish
- Italy · Abis, Almidis
- Lithuania · Agen, Alneta
- Luxembourg · Amlodipin Besilaat Sandoz, Amlodipine Amlodipine Taw Pharma 1 mg/Ml Suspension Buvable
- Latvia · Agen, Amlodipine Vitabalans
- Malta · Amlodipina Ipca, Amlodipine Accord Healthcare
- Netherlands · Amlober, Amlodipine (Als Besilaat) Accord
- Norway · Amlodipin Accord, Amlodipin Sandoz
- Poland · Adipine, Agen
- Portugal · Amlocor, Amlodipina Accord
- Romania · Almacor, Amlodipină Arena
- Sweden · Amlodipin, Amlodipin Accord
- Slovenia · Amlodipin Alkaloid-Int, Amlodipin Krka D.D.
- Slovakia · Agen, Amlodipin Ratiopharm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f71bfd0a-bad3-44e4-bc99-39db17be465f GET /v1/drugs/f71bfd0a-bad3-44e4-bc99-39db17be465f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62204255",
"date_amm": "1990-12-26",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "AMLODIPINE (BÉSILATE D')",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about amlodipine (bésilate d').
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.